Safety outcomes of darolutamide vs apalutamide and enzalutamide in nmCRPC

  Рет қаралды 1,287

VJOncology

VJOncology

Күн бұрын

Neal Shore, MD, Carolina Urologic Research Center, Myrtle Beach, SC, discusses the safety outcomes of darolutamide versus apalutamide and enzalutamide in non-metastatic castration-resistant prostate cancer (nmCRPC) using matching-adjusted indirect comparisons. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Пікірлер
New FDA Approval: Darolutamide for Hormone-Sensitive Disease | Mark Scholz, MD | PCRI
12:08
New FDA Approval: Darolutamide for Hormone-Sensitive Disease | Mark Scholz, MD | PCRI
Prostate Cancer Research Institute
Рет қаралды 15 М.
Self Advocate and Do Your Own Research | Howard Wolinsky’s #ProstateCancer Patient Story | PCRI
18:40
Self Advocate and Do Your Own Research | Howard Wolinsky’s #ProstateCancer Patient Story | PCRI
Prostate Cancer Research Institute
Рет қаралды 9 М.
бабл ти гель для душа // Eva mash
01:00
бабл ти гель для душа // Eva mash
EVA mash
Рет қаралды 7 МЛН
REAL MAN 🤣💪🏻
00:35
REAL MAN 🤣💪🏻
Kan Andrey
Рет қаралды 4,6 МЛН
Family Love #funny #sigma
00:16
Family Love #funny #sigma
CRAZY GREAPA
Рет қаралды 35 МЛН
ЗНАЛИ? ТОЛЬКО ОАЭ 🤫
00:13
ЗНАЛИ? ТОЛЬКО ОАЭ 🤫
Сам себе сушист
Рет қаралды 4 МЛН
Live long and PROSPER: enzalutamide for nmCRPC
3:19
Live long and PROSPER: enzalutamide for nmCRPC
VJOncology
Рет қаралды 1,7 М.
Apalutamide, ADT Improve Outcomes in High-Risk Prostate Cancer Post-Surgery
6:12
Apalutamide, ADT Improve Outcomes in High-Risk Prostate Cancer Post-Surgery
GU Oncology Now
Рет қаралды 887
The Groundbreaking Cancer Expert: (New Research) "This Common Food Is Making Cancer Worse!"
1:37:34
The Groundbreaking Cancer Expert: (New Research) "This Common Food Is Making Cancer Worse!"
The Diary Of A CEO
Рет қаралды 3,1 МЛН
Patient Selection in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
16:26
Patient Selection in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Grand Rounds in Urology
Рет қаралды 1,7 М.
ARAMON: darolutamide versus enzalutamide monotherapy in CSPC
2:12
ARAMON: darolutamide versus enzalutamide monotherapy in CSPC
VJOncology
Рет қаралды 544
Sulforaphane and Its Effects on Cancer, Mortality, Aging, Brain and Behavior, Heart Disease & More
47:43
Sulforaphane and Its Effects on Cancer, Mortality, Aging, Brain and Behavior, Heart Disease & More
FoundMyFitness
Рет қаралды 2,4 МЛН
Reducing Side Effects of Hormone Therapy for Prostate Cancer | Prostate Cancer Staging Guide
10:09
Reducing Side Effects of Hormone Therapy for Prostate Cancer | Prostate Cancer Staging Guide
Prostate Cancer Research Institute
Рет қаралды 135 М.
16 Years: Surviving Metastatic #ProstateCancer | Joel Nowak, CEO of @cancerabcs4642 | #PCRI
13:30
16 Years: Surviving Metastatic #ProstateCancer | Joel Nowak, CEO of @cancerabcs4642 | #PCRI
Prostate Cancer Research Institute
Рет қаралды 90 М.
Latest Advances in Advanced Prostate Cancer Treatment | 2024 ZERO Prostate Cancer Summit
56:54
Latest Advances in Advanced Prostate Cancer Treatment | 2024 ZERO Prostate Cancer Summit
ZERO Prostate Cancer
Рет қаралды 3,6 М.
Advances in recurrent endometrial cancer: adavosertib, a WEE1 inhibitor
3:54
Advances in recurrent endometrial cancer: adavosertib, a WEE1 inhibitor
VJOncology
Рет қаралды 1,2 М.
бабл ти гель для душа // Eva mash
01:00
бабл ти гель для душа // Eva mash
EVA mash
Рет қаралды 7 МЛН